Article Link: FDA Approves Merck’s Keytruda (pembrolizumab) for Classical Hodgkin Lymphoma (cHL) Source: FDA New Drug Appro...
FDA Approves Kisqali (ribociclib) for HR+/HER2- Metastatic Breast Cancer
Article Link: FDA Approves Kisqali (ribociclib) for HR+/HER2- Metastatic Breast Cancer Source: FDA New Drug Approvals
FDA Approves Noctiva (desmopressin acetate) Nasal Spray for Nocturia in Adults
Article Link: FDA Approves Noctiva (desmopressin acetate) Nasal Spray for Nocturia in Adults Source: FDA New Drug Approvals
FDA Approves Odactra for House Dust Mite Allergies
Article Link: FDA Approves Odactra for House Dust Mite Allergies Source: FDA New Drug Approvals
FDA Approves Xermelo (telotristat ethyl) as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors
Article Link: FDA Approves Xermelo (telotristat ethyl) as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metast...
FDA Approves Once-Daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes
Article Link: FDA Approves Once-Daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes Source:...
FDA Expands Indication for Revlimid (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT)
Article Link: FDA Expands Indication for Revlimid (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous He...
FDA Expands Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Article Link: FDA Expands Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children ...
FDA Approves Siliq (brodalumab) for Plaque Psoriasis
Article Link: FDA Approves Siliq (brodalumab) for Plaque Psoriasis Source: FDA New Drug Approvals
FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy
Article Link: FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy Source: FDA New Drug Approvals